Which strategy supports balanced replacement in massive hemorrhage management?

• A. Reduces need for crystalloids by replacing fluids
• B. Provides balanced replacement of red cells, plasma, and platelets to prevent coagulopathy and improve survival
• C. Increases risk of coagulopathy
• D. Uses crystalloids alone

Answer: (B)

In massive hemorrhage, you’re not just replacing blood loss; you’re reconstituting both oxygen delivery and the body’s clotting machinery. Replacing red cells alone restores oxygen-carrying capacity, but it doesn’t fix the missing clotting factors and platelets that drive hemostasis. Providing a balanced replacement of red cells, plasma, and platelets supplies the necessary components for clot formation while still restoring volume. This approach helps prevent dilutional coagulopathy that happens when large amounts of crystalloids or red cells are given without coagulation factors, and it is associated with improved survival in severe bleeding. Using crystalloids alone fails to correct coagulopathy and can worsen bleeding and edema, while aiming for a balanced, rapid transfusion of blood components directly addresses the needs of the patient during massive hemorrhage.